China SXT Pharmaceuticals (SXTC) Assets Average (2020 - 2025)
China SXT Pharmaceuticals has reported Assets Average over the past 6 years, most recently at $24.0 million for Q3 2025.
- For Q3 2025, Assets Average fell 11.28% year-over-year to $24.0 million; the TTM value through Sep 2025 reached $24.0 million, down 11.28%, while the annual FY2025 figure was $22.4 million, 14.98% down from the prior year.
- Assets Average for Q3 2025 was $24.0 million at China SXT Pharmaceuticals, down from $26.3 million in the prior quarter.
- Over five years, Assets Average peaked at $29.3 million in Q1 2021 and troughed at $18.9 million in Q1 2024.
- A 5-year average of $25.8 million and a median of $26.7 million in 2024 define the central range for Assets Average.
- Biggest five-year swings in Assets Average: fell 27.1% in 2024 and later surged 39.63% in 2025.
- Year by year, Assets Average stood at $28.6 million in 2021, then fell by 2.6% to $27.9 million in 2022, then fell by 20.79% to $22.1 million in 2023, then grew by 22.61% to $27.1 million in 2024, then decreased by 11.28% to $24.0 million in 2025.
- Business Quant data shows Assets Average for SXTC at $24.0 million in Q3 2025, $26.3 million in Q1 2025, and $27.1 million in Q3 2024.